9 Reporting in Brachytherapy: Dose and Volume Specification

214 Reporting in Brachytherapy

(1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Bull Cancer Radiother 2000; 4 :159-72. 89. Pötter R. Modern imaging methods used for treatment planning and quality assurance for combined irradiation of cervix cancer, Workshop "Integration of external beam therapy and brachytherapy in the treatment of cervix cancer: clinical, physical and biological aspects. Annual Brachytherapy Meeting GEC-ESTRO Stockholm, 5-7 May 1997; European Society for Therapeutic Radiology and Oncology. Groupe Europ6én de Curiethérapie 1997; 27-38. 90. Pötter R, Kovacs G, Haverkamp U. 3D Conformal Therapy in Brachytherapy. 8 th International Brachytherapy Conference Nice, France. Nucletron-Oldelft 1995; Veenendaal The Netherlands. 91. Quimby EH, Castro V. The calculation of dosage in interstitial radium therapy. Am J Roentgenol 1953; 70 : 739-49. 92. Resch A, Pötter R, Van Limbergen E, et al. Long Term Results (10 years) of Intensive Breast Conserving Therapy Including a High Dose and Large Volume Interstitial Brachytherapy Boost (LDR/HDR) for T1/T2-Breast Cancer. Radiother Oncol (in press) 2002. 93. Roeske JC, Mundt AJ, Halpern H, et al. Late rectal sequelae following definitive radiation therapy for carcinoma of uterine cervix: a dosimetric analysis. Int J Radiat Oncol Biol Phys 1997; 37 : 351-58. 94. Ryberg M, Björkholm E, Båryd I, et al. Adaptation of the Stockholm cervical cancer treatment technique to Selectron afterloading. A preliminary report. Brachytherapy Working Conference. 6 th International Selectron User's Meeting 1990; Florence, Italy. 95. Saarnak AE, Boersma M, van Bunningen BNFM, et al. Interobserver variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer. Radiother Oncol 2000; 56 : 37-42. 96. Saw CB, Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys 1991; 20 : 135-39. 97. Schoeppel S, La Vigne M, Martel M. Three dimensional treatment planning of intracavitary gynecologic implants : analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 1993; 28 : 277-83. 98. SFPH, Société Française des Physiciens d'Hôpital. Contrôle de qualité en curiethérapie par iridium-192 à haut débit de dose.Commission de Curiethérapie, Ed. Société Française des Physiciens d'Hôpital - Institut Curie 1995; Rapport N#11 . 26 Rue d'Ulm, 75231 Paris Cedex, France. 99. Steggerda MJ, Moonen LMF, Damen EMP, et al. An analysis of the effects of ovoids shields in a selectron LDR cervical applicator on dose distributions in rectum and bladder. Int J Radiat Oncol Biol Phys 1997; 39 : 237-45. 100. Stryker JA, et al. Bladder and rectal complications following radiotherapy for cervix cancer. Gyn Onc 1988; 19: 1-11. 101. Tod M, Meredith WJ. Treatment of cancer of the cervix uteri: A revised Manchester method. Br J Radiol 1953; 26 : 252-57. 102. UICC, International Union Against Cancer. TNM Classification of Malignant Tumours, 5 th edition (ed. Sobin LH, Wittekind CH) 1997; New York, Wiley-Liss and Sons. 103. UICC, International Union Against Cancer. TNM Atlas, Illustrated Guide to the TNM/pTNM. Classification of malignant tumours, 4th edition (ed. Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind CH) 1998; Springer Berlin, Heidelberg. 104. Van den Bergh F, Meertens H, Moonen L, et al. The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol 1998; 47 : 85-90. 105. Van Der Laarse R, Luthmann RW. Computers in brachytherapy dosimetry, in Joslin CA, Flynn A, Hall EJ. (eds). Principles and practice of brachytherapy , using afterloading systems 2001; ARNOLD, London: 49-80. 106. Van Der Laarse R, Prins TPE. Comparing the Stepping Source Dosimetry System and the Paris System using volume-dose histograms of breast implants. In Brachytherapy from